8 results on '"Van Stavern, Gregory P."'
Search Results
2. Incidence and Causes of Overdiagnosis of Optic Neuritis: Physician Insecurity-Reply.
- Author
-
Stunkel L, Kung NH, and Van Stavern GP
- Subjects
- Humans, Incidence, Medical Overuse, Optic Neuritis, Physicians
- Published
- 2018
- Full Text
- View/download PDF
3. An Eye on Brain Integrity: Acute Optic Neuritis Affects Resting State Functional Connectivity.
- Author
-
Wu GF, Brier MR, Parks CA, Ances BM, and Van Stavern GP
- Subjects
- Acute Disease, Adult, Brain pathology, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging, Male, Optic Neuritis diagnosis, Prospective Studies, Tomography, Optical Coherence, Visual Pathways pathology, Young Adult, Brain physiopathology, Optic Neuritis physiopathology, Rest physiology, Visual Acuity, Visual Pathways physiopathology
- Abstract
Purpose: Currently, the ability for imaging to capture brain adaptations to injury that occurs in multiple sclerosis (MS) is limited. In particular, how the brain initially contends with the earliest clinical manifestations of white matter injury has yet to be defined. The purpose of this study was to determine the impact of acute optic neuritis (ON) on resting state functional connectivity magnetic resonance imaging (rs-fcMRI)., Methods: Fifteen patients with a clinically isolated syndrome of acute ON were evaluated at an academic center in a prospective study. Subjects were assessed with structural and functional vision measures, including optical coherence tomography (OCT), high- and low-contrast letter acuity testing, and visual fields and quality-of-life measures (VFQ-25). The rs-fcMRI was compared with age- and sex-matched healthy controls., Results: We observed reduced functional connectivity within the visual system and a loss of anticorrelations between the visual system and nonvisual networks. Stronger functional connectivity between visual regions correlated with better quality of life, as measured by the VFQ-25, and better acuity scores for both high- and low-contrast testing in the affected eye., Conclusions: The rs-fcMRI functional connectivity changes within (intranetwork) and between (internetwork) resting state networks occur after acute ON, indicating immediate cortical responses to focal inflammatory demyelination. Thus, focal white matter injury in the central nervous system acutely results in widespread network alterations that may lead to functional neurologic changes seen in MS.
- Published
- 2015
- Full Text
- View/download PDF
4. Should optical coherence tomography be used to manage patients with multiple sclerosis?
- Author
-
Costello F and Van Stavern GP
- Subjects
- Adult, Disease Progression, Female, Humans, Multiple Sclerosis complications, Optic Neuritis diagnosis, Optic Neuritis etiology, Tomography, Optical Coherence methods
- Published
- 2012
- Full Text
- View/download PDF
5. Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis.
- Author
-
Khanna S, Sharma A, Huecker J, Gordon M, Naismith RT, and Van Stavern GP
- Subjects
- Adult, Brain pathology, Female, Humans, Male, Middle Aged, Optic Nerve pathology, Retrospective Studies, Spinal Cord pathology, Young Adult, Magnetic Resonance Imaging, Multiple Sclerosis complications, Neuromyelitis Optica complications, Optic Neuritis etiology, Optic Neuritis pathology
- Abstract
Background: Patients with neuromyelitis optica (NMO) and multiple sclerosis (MS) both can present with acute optic neuritis (ON), while differing considerably in their prognosis and management. The clinical course, serologic testing results, and brain and spinal cord imaging of these diseases have been well documented. The purpose of this study was to look systematically for any differences in the imaging appearance of the optic nerve in NMO and MS-related ON., Methods: Magnetic resonance imaging (MRI) of brain and orbits obtained within 6 weeks of acute ON in patients with securely diagnosed NMO (n = 6) and MS (n = 11) were retrospectively analyzed by a neuroradiologist masked to the clinical diagnosis. Standardized scoring system was used to assess and analyze the extent and nature of optic pathway involvement., Results: No significant differences were observed in the presence, degree, or the type of signal alteration and contrast enhancement of the affected nerve segments between NMO and MS groups. There was a trend toward more posterior involvement of the optic nerve in the NMO group with chiasmatic enhancement exclusively seen in NMO patients., Conclusion: We found a higher propensity of NMO-related ON to affect more posterior parts of the optic nerve, including chiasm, and have simultaneous bilateral disease. Further study with larger sample sizes is needed.
- Published
- 2012
- Full Text
- View/download PDF
6. Adalimumab-associated optic neuritis.
- Author
-
Chung JH, Van Stavern GP, Frohman LP, and Turbin RE
- Subjects
- Adalimumab, Adult, Anti-Inflammatory Agents therapeutic use, Antibodies, Monoclonal, Humanized, Arthritis, Psoriatic drug therapy, Arthritis, Psoriatic immunology, Arthritis, Psoriatic physiopathology, Arthritis, Rheumatoid drug therapy, Arthritis, Rheumatoid immunology, Arthritis, Rheumatoid physiopathology, Humans, Immunity, Cellular drug effects, Immunity, Cellular immunology, Magnetic Resonance Imaging, Male, Methylprednisolone Hemisuccinate therapeutic use, Middle Aged, Optic Nerve pathology, Optic Nerve physiopathology, Optic Neuritis diagnosis, Optic Neuritis physiopathology, Treatment Outcome, Vision, Low chemically induced, Vision, Low diagnosis, Vision, Low physiopathology, Antibodies, Monoclonal adverse effects, Immunosuppressive Agents adverse effects, Optic Nerve drug effects, Optic Neuritis chemically induced, Tumor Necrosis Factor-alpha antagonists & inhibitors
- Abstract
We present, to our knowledge, the first published cases of optic neuritis associated with adalimumab, a medication in the class of anti-tumor necrosis factor-alpha (TNF-alpha) antagonists. Approved in recent years by the FDA, adalimumab (Humira, Abbott Laboratories; Abbott Park, IL) is a recombinant monoclonal antibody that targets and blocks the physiologic effects of TNF. Other TNF antagonists have had associations with optic neuritis and demyelinating events.
- Published
- 2006
- Full Text
- View/download PDF
7. Peripheral Retinal Haemorrhages in a Patient with MOG-Associated Optic Neuritis.
- Author
-
Wilke, Georgia A., Spencer, Madeline, Gilman, Carley A., Guerriero, Rejean, Bohm, Parker, Van Stavern, Gregory P., and Lee, Andrew R.
- Subjects
OPTIC neuritis ,MYELIN oligodendrocyte glycoprotein ,HEMORRHAGE ,MAGNETIC resonance imaging ,OPTIC nerve ,VISION disorders - Abstract
A 15-year-old female presented with headaches and bilateral vision loss. Fundoscopic examination revealed bilateral optic nerve oedema as well as peripheral retinal haemorrhages. Magnetic resonance imaging of the brain showed findings consistent with bilateral optic neuritis. The patient was started on high dose intravenous corticosteroids but her vision failed to improve. The presence of retinal haemorrhages raised concern that a vasculitis was underlying her symptoms, prompting an extensive work-up, which was unrevealing. Plasmapheresis was initiated and the patient's vision eventually improved to 20/20 in both eyes. Ultimately, she was found to be positive for myelin oligodendrocyte glycoprotein (MOG) antibodies, consistent with a diagnosis of MOG-associated optic neuritis. The patient's course was typical for MOG-associated optic neuritis but her peripheral retinal haemorrhages were atypical, which created diagnostic uncertainty. It is important to be aware of the possibility of retinal findings in this disease. We also review potential causes for retinal haemorrhages in optic neuritis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Patient Harm Due to Diagnostic Error of Neuro-Ophthalmologic Conditions.
- Author
-
Stunkel, Leanne, Sharma, Rahul A., Mackay, Devin D., Wilson, Bradley, Van Stavern, Gregory P., Newman, Nancy J., and Biousse, Valérie
- Subjects
- *
DIAGNOSTIC errors , *VISION disorders , *DIAGNOSIS , *PATIENTS' attitudes , *CRANIAL nerves , *DIPLOPIA , *OPTIC neuritis - Abstract
To prospectively examine diagnostic error of neuro-ophthalmic conditions and resultant harm at multiple sites. Prospective, cross-sectional study. A total of 496 consecutive adult new patients seen at 3 university-based neuro-ophthalmology clinics in the United States in 2019 to 2020. Collected data regarding demographics, prior care, referral diagnosis, final diagnosis, diagnostic testing, treatment, patient disposition, and impact of the neuro-ophthalmologic encounter. For misdiagnosed patients, we identified the cause of error using the Diagnosis Error Evaluation and Research (DEER) taxonomy tool and whether the patient experienced harm due to the misdiagnosis. The primary outcome was whether patients who were misdiagnosed before neuro-ophthalmology referral experienced harm as a result of the misdiagnosis. Secondary outcomes included appropriateness of referrals, misdiagnosis rate, interventions undergone before referral, and the primary type of diagnostic error. Referral diagnosis was incorrect in 49% of cases. A total of 26% of misdiagnosed patients experienced harm, which could have been prevented by earlier referral to neuro-ophthalmology in 97%. Patients experienced inappropriate laboratory testing, diagnostic imaging, or treatment before referral in 23%, with higher rates for patients misdiagnosed before referral (34% of patients vs. 13% with a correct referral diagnosis, P < 0.0001). Seventy-six percent of inappropriate referrals were misdiagnosed, compared with 45% of appropriate referrals (P < 0.0001). The most common reasons for referral were optic neuritis or optic neuropathy (21%), papilledema (18%), diplopia or cranial nerve palsies (16%), and unspecified vision loss (11%). The most common sources of diagnostic error were the physical examination (36%), generation of a complete differential diagnosis (24%), history taking (24%), and use or interpretation of diagnostic testing (13%). In 489 of 496 patients (99%), neuro-ophthalmology consultation (NOC) affected patient care. In 2% of cases, neuro-ophthalmology directly saved the patient's life or vision; in an additional 10%, harmful treatment was avoided or appropriate urgent referral was provided; and in an additional 48%, neuro-ophthalmology provided a diagnosis and direction to the patient's care. Misdiagnosis of neuro-ophthalmic conditions, mismanagement before referral, and preventable harm are common. Early appropriate referral to neuro-ophthalmology may prevent patient harm. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.